Shots: The submissions are based on P-III GO-VIVA study involves assessing of SIMPONI ARIA in 127 patients aged 2-17yrs. with active pJIA having arthritis in 5or more joints, despite current treatment with methotrexate for at least two mos. The focus of the study is to evaluate PK safety & efficacy of the therapy in pediatric […]Read More
